Cyclin-D1 expression in human renal-cell carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Cyclin D1 is a proto-oncogene frequently altered in malignancies, regulating the G1-S cell cycle transition.
• Aberrations in G1-S transition are common in cancers, but poorly understood in human renal cell carcinoma (RCC).

Purpose of the Study:

• To characterize cyclin D1 expression in human renal cell carcinoma (RCC).
• To investigate the correlation between cyclin D1 expression and clinicopathological features and prognosis in RCC.

Main Methods:

• Western blotting was used to quantify cyclin D1 protein levels in 80 RCC tissues and 12 normal kidney cortex samples.
• Immunohistochemistry assessed cyclin D1 expression in a subset of tumors.
• Ki-67 antigen expression and S-phase analysis were used to determine proliferation rates.

Main Results:

• 75% of RCC tumors exhibited higher cyclin D1 levels than normal kidney cortex; 25% showed low or absent cyclin D1.
• Cyclin D1 expression did not correlate with proliferation markers (Ki-67, S-phase).
• In non-papillary RCC, high cyclin D1 expression was linked to diploid DNA, smaller tumor size, and significantly better prognosis (p=0.005 univariate, p=0.002 multivariate).

Conclusions:

• Cyclin D1 expression is highly variable in RCC, potentially indicating activation in a subset of tumors.
• High cyclin D1 expression in non-papillary RCC is a favorable prognostic marker, independent of tumor stage or grade.
• Further research is needed to elucidate the precise role of cyclin D1 in RCC pathogenesis and progression.